49 results
424B7
RLAY
Relay Therapeutics Inc
10 Jan 24
Prospectus with selling stockholder info
9:22am
and programs;
developments relating to our competitors and our industry;
the effect of the COVID-19 pandemic, including mitigation efforts and economic effects
424B7
RLAY
Relay Therapeutics Inc
16 Nov 23
Prospectus with selling stockholder info
4:16pm
of laws and regulations on our business and programs;
developments relating to our competitors and our industry;
the effect of the COVID-19 pandemic
8-K
EX-99.1
4axfpurerjuu
3 Nov 22
Relay Therapeutics Reports Third Quarter 2022 Financial Results and Corporate Highlights
4:11pm
424B5
3zz z9bg67c310hs3c
13 Sep 22
Prospectus supplement for primary offering
5:19pm
424B5
414ogl97pczfhlfle
12 Sep 22
Prospectus supplement for primary offering
7:35am
424B7
0bv2pmn
1 Sep 22
Prospectus with selling stockholder info
4:06pm
8-K
EX-99.1
z523xmo8kv5 25amm
4 Aug 22
Relay Therapeutics Reports Second Quarter 2022 Financial Results and Corporate Highlights
4:32pm
8-K
1737p9j
27 Jun 22
Regulation FD Disclosure
6:11am
8-K
EX-99.2
7sir6ik320c
27 Jun 22
Regulation FD Disclosure
6:11am
8-K
EX-99.1
5daq 024p
27 Jun 22
Regulation FD Disclosure
6:11am
8-K
EX-99.1
84uq8rhoq5gkv
5 May 22
Relay Therapeutics Reports First Quarter 2022 Financial Results and Corporate Highlights
12:00am